Skip to main content
Toggle navigation
Search
Home
Icon Legend
Food/Drinks Available
CE's Available
Reception
Pre-registration Required
Livestreaming
Recorded Session
Back
Tweet this
Laura Zelazoski
Poster(s):
(163) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in children 6 years and older with cystic fibrosis and ≥1
F508del
allele: 96-week interim results from an open-label extension study
Thursday, November 3, 2022
12:45 PM – 1:25 PM
ET
(185) Long-term safety and efficacy of elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for
F508del-CFTR
and a gating or residual function mutation
Thursday, November 3, 2022
12:45 PM – 1:25 PM
ET
